Brentuximab Vedotin Therapy for Cutaneous Lesions in T-Prolymphocytic Leukemia: A Case Report
We present an 88-year-old male with simultaneous T-cell prolymphocytic leukemia and stable smoldering myeloma with excellent initial response to three months of alemtuzumab. The patient relapsed at twelve months with severe cutaneous disease. Biopsy of a representative plaque demonstrated CD30 posit...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
PAGEPress Publications, Pavia, Italy
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062622/ |